No genetic association detected with mepolizumab efficacy in severe asthma.

Respiratory Medicine(2017)

引用 19|浏览51
暂无评分
摘要
•Efficacy pharmacogenetics of mepolizumab treatment in patients with severe asthma was investigated.•A candidate polymorphism analysis and an unbiased genome-wide association analyses were performed.•No genetic effect on mepolizumab treatment response was identified.
更多
查看译文
关键词
Severe asthma,Mepolizumab,Pharmacogenetics,Exacerbation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要